编辑、出版者、影响因子和重印收入。
Editors, publishers, impact factors, and reprint income.
机构信息
Clinical Risk, RSM Press Ltd., London, United Kingdom.
出版信息
PLoS Med. 2010 Oct 26;7(10):e1000355. doi: 10.1371/journal.pmed.1000355.
Abstract
Harvey Marcovitch discusses new research findings from Andreas Lundh and colleagues that examined the effect of publishing industry-funded clinical trials on journal citations and reprint income at six major medical journals.
摘要
哈维·马尔科维奇讨论了安德烈亚斯·伦德和同事的新研究发现，该研究考察了出版业资助的临床试验对六本主要医学期刊的期刊引用和重印收入的影响。
相似文献
1
Editors, publishers, impact factors, and reprint income.编辑、出版者、影响因子和重印收入。
PLoS Med. 2010 Oct 26;7(10):e1000355. doi: 10.1371/journal.pmed.1000355.
2
[High impact pediatric journals in the back stage].
An Pediatr (Engl Ed). 2018 May;88(5):295-296. doi: 10.1016/j.anpedi.2018.02.001. Epub 2018 Mar 24.
3
Joint ownership: the shared responsibilities of journal editors and publishers.共同所有权：期刊编辑与出版商的共同责任
Md Med. 2007 Winter;8(1):10-2.
4
Finances of the publishers of the most highly cited US medical journals.美国被引用次数最多的医学期刊出版商的财务状况。
J Med Libr Assoc. 2011 Jul;99(3):255-8. doi: 10.3163/1536-5050.99.3.013.
5
How to Get Published: What Are Journal Editors Looking for?
Heart Lung Circ. 2017 Jun;26(6):533-535. doi: 10.1016/j.hlc.2017.04.001.
6
[1999, the year of fired editors-in-chief].[1999年，主编被解雇之年]
Ned Tijdschr Geneeskd. 2000 Jan 1;144(1):3-4.
7
Strong medicine for China's journals.给中国期刊的猛药。
Nature. 2010 Sep 16;467(7313):261. doi: 10.1038/467261a.
8
Declaration of financial interests.财务利益声明。
Nat Biotechnol. 2001 Oct;19(10):892. doi: 10.1038/nbt1001-892.
9
Lancet publisher to sell arms business.《柳叶刀》出版商将出售军火业务。
CMAJ. 2007 Jul 31;177(3):242. doi: 10.1503/cmaj.070884.
10
Perilous terra incognita--open-access journals.危险的未知领域——开放获取期刊。
Acad Psychiatry. 2014 Apr;38(2):221-3. doi: 10.1007/s40596-014-0059-1. Epub 2014 Feb 12.
引用本文的文献
1
Determinants of impact factor and Eigenfactor score in otolaryngology journals.耳鼻咽喉科学期刊影响因子和特征因子得分的决定因素
Laryngoscope Investig Otolaryngol. 2023 Feb 6;8(2):380-393. doi: 10.1002/lio2.1018. eCollection 2023 Apr.
2
The state of population health research performance in the Middle East and North Africa: a meta-research study.中东和北非人口健康研究绩效状况：一项元研究。
Syst Rev. 2021 Jan 2;10(1):1. doi: 10.1186/s13643-020-01552-x.
3
Causal language and strength of inference in academic and media articles shared in social media (CLAIMS): A systematic review.社交媒体分享的学术和媒体文章中的因果语言和推理强度（CLAIMS）：系统评价。
PLoS One. 2018 May 30;13(5):e0196346. doi: 10.1371/journal.pone.0196346. eCollection 2018.
4
Backing up Ayurveda with good science: The modus operandi.用可靠的科学支持阿育吠陀医学：操作方法。
Anc Sci Life. 2015 Apr-Jun;34(4):185-7. doi: 10.4103/0257-7941.160861.
5
Impact of article language in multi-language medical journals--a bibliometric analysis of self-citations and impact factor.多语种医学期刊中文章语言的影响——基于自引率和影响因子的文献计量分析
PLoS One. 2013 Oct 17;8(10):e76816. doi: 10.1371/journal.pone.0076816. eCollection 2013.
6
Why full open access matters.为什么全文开放访问很重要。
PLoS Biol. 2011 Nov;9(11):e1001210. doi: 10.1371/journal.pbio.1001210. Epub 2011 Nov 29.
7
Development of a practical tool to measure the impact of publications on the society based on focus group discussions with scientists.基于与科学家的焦点小组讨论，开发一种实用工具来衡量出版物对社会的影响。
BMC Public Health. 2011 Jul 25;11:588. doi: 10.1186/1471-2458-11-588.
本文引用的文献
1
Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.医学期刊的利益冲突：行业支持的随机试验对期刊影响因子和收入的影响 - 队列研究。
PLoS Med. 2010 Oct 26;7(10):e1000354. doi: 10.1371/journal.pmed.1000354.
2
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.专业医学协会及其与行业的关系：关于控制利益冲突的提议。
JAMA. 2009 Apr 1;301(13):1367-72. doi: 10.1001/jama.2009.407.
3
Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.根据资金来源划分的主要心血管临床试验的差异引用率：2000年至2005年的一项调查
Circulation. 2008 Sep 23;118(13):1321-7. doi: 10.1161/CIRCULATIONAHA.108.794016. Epub 2008 Sep 8.
4
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.与罗非昔布相关出版物中的客座作者身份和代笔行为：以罗非昔布诉讼中的行业文件为例
JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800.
5
Factors associated with citation rates in the orthopedic literature.骨科文献中与引用率相关的因素。
Can J Surg. 2007 Apr;50(2):119-23.
6
Characteristics associated with citation rate of the medical literature.与医学文献被引频次相关的特征。
PLoS One. 2007 May 2;2(5):e403. doi: 10.1371/journal.pone.0000403.
7
Press-released papers are more downloaded and cited.新闻发布的论文被下载和引用的次数更多。
Tob Control. 2007 Feb;16(1):71. doi: 10.1136/tc.2006.019034.
8
Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.报告利益冲突、研究的财务方面以及资助者在受资助研究中的作用。
JAMA. 2005 Jul 6;294(1):110-1. doi: 10.1001/jama.294.1.110.
9
Pharmaceutical industry sponsorship and research outcome and quality: systematic review.制药行业赞助与研究结果及质量：系统评价
BMJ. 2003 May 31;326(7400):1167-70. doi: 10.1136/bmj.326.7400.1167.
10
Importance of the lay press in the transmission of medical knowledge to the scientific community.大众媒体在向科学界传播医学知识方面的重要性。
N Engl J Med. 1991 Oct 17;325(16):1180-3. doi: 10.1056/NEJM199110173251620.
Zotero 插件